ALDH3A2 Antibodies

Santa Cruz Biotechnology provides a broad selection of ALDH3A2 monoclonal antibodies for research focused on understanding this important enzyme. ALDH3A2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALDH3A2, or aldehyde dehydrogenase 3 family member A2, plays a crucial role in the detoxification of aldehydes and is involved in the metabolism of retinoids, which are vital for vision and cellular function. Dysregulation of ALDH3A2 has been linked to various diseases, including certain cancers and neurodegenerative disorders, highlighting its significance in both health and disease. ALDH3A2 research has revealed important insights into cellular detoxification pathways and their impact on human health. Understanding ALDH3A2 function and regulation can provide valuable information about disease mechanisms and potential therapeutic targets. Investigating ALDH3A2 expression patterns helps researchers better understand tissue-specific roles and regulatory mechanisms. Recent studies have shown ALDH3A2's involvement in lipid metabolism and cellular stress responses. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ALDH3A2 and its role in human health and disease.